Yahoo Web Search

Search results

    • Small Business - The Brewton Standard | The Brewton Standard

      The Brewton Standard· 2 hours ago

      Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations New real-world evidence shows Beyfortus (nirsevimab) substantially reduced RSV lower respiratory tract disease and hospitalizations in